Stocktoria
CONMED Corp CNMD
NYSE · XNYS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1987-07-23
CONMED Corp financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.3B | $1.2B | $1.0B | $1.0B |
| Gross profit | $750.5M | $733.0M | $676.2M | $571.2M | $568.0M |
| R&D expense | $55.9M | $54.4M | $52.6M | $47.2M | $43.6M |
| SG&A expense | $592.0M | $478.3M | $503.0M | $454.0M | $414.8M |
| Operating income | $102.6M | $200.3M | $120.6M | $70.1M | $109.7M |
| Interest expense | $31.1M | $37.3M | $39.8M | $28.9M | $35.5M |
| Income tax | $24.1M | $30.6M | $16.4M | $9.7M | $10.6M |
| Net income | $47.1M | $132.4M | $64.5M | -$80.6M | $62.5M |
| EPS (diluted) | $1.51 | $4.25 | $2.04 | $-2.68 | $1.94 |
| Operating cash flow | $170.7M | $167.0M | $125.3M | $33.4M | $111.8M |
| Free cash flow | $150.9M | $153.9M | $106.3M | $11.6M | $96.9M |
| Inventory | $355.5M | $346.7M | $318.3M | $332.3M | $231.6M |
| Total assets | $2.3B | $2.3B | $2.3B | $2.3B | $1.8B |
| Total liabilities | $1.3B | $1.3B | $1.5B | $1.6B | $980.6M |
| Shareholders' equity | $1.0B | $962.7M | $834.2M | $745.5M | $785.4M |
Source: SEC EDGAR filings · CIK 0000816956 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.